D. Hoffman

发表

Localization of drug reward mechanisms by intracranial injections

R. Wise, D. Hoffman, 1992, Synapse.

The dopamine D2 receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with l-dopa

J. Kehne, D. Hoffman, P. Jenner, 2009, Journal of Neural Transmission.

Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits.

D. Hoffman, Julie L. Piechan, F. Bian, 2011, European journal of pharmacology.

Effects of the CRF1 receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups

J. Kehne, D. Hoffman, J. Cassella, 2000, Neuropharmacology.

2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors.

A Thurkauf, D K Jones-Hertzog, D. Hoffman, 1997, Journal of medicinal chemistry.

Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.

He Zhao, D. Hoffman, R. Brodbeck, 2002, Bioorganic & medicinal chemistry letters.

Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats

R. Beninger, D. Hoffman, B. Hahn, 2004, Psychopharmacology.

Receptor subtype-specific dopaminergic agents and conditioned behavior

R. Beninger, D. Hoffman, E. Mazurski, 1989, Neuroscience & Biobehavioral Reviews.

Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats

R. Wise, D. Hoffman, T. E. West, 1991, Brain Research.

The Newly Developed CRF1-Receptor Antagonists, NGD 98-2 and NGD 9002, Suppress Acute Stress-Induced Stimulation of Colonic Motor Function and Visceral Hypersensitivity in Rats

J. Kehne, D. Hoffman, Y. Taché, 2013, PloS one.

The effects of pimozide on the establishment of conditioned reinforcement as a function of the amount of conditioning

R. Beninger, D. Hoffman, 2004, Psychopharmacology.

The D1 dopamine receptor antagonist, SCH 23390 reduces locomotor activity and rearing in rats

R. Beninger, D. Hoffman, 1985, Pharmacology Biochemistry and Behavior.

Models of Schizophrenia: Phencyclidine Disruption of Prepulse Inhibition (PPI) of Startle in Rats

J. Kehne, D. Hoffman, J. Cassella, 1998 .

D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia

D. Hoffman, H. Donovan, 1994, Psychopharmacology.

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

D. Hoffman, H. Donovan, 1995, Psychopharmacology.

Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.

Ping Ge, Taeyoung Yoon, Dario Doller, 2011, Journal of medicinal chemistry.

2-Arylpyrimidines: novel CRF-1 receptor antagonists.

J. Kehne, J. Chandrasekhar, D. Hoffman, 2008, Bioorganic & medicinal chemistry letters.

The design, synthesis and structure-activity relationships of 1-aryl-4-aminoalkylisoquinolines: a novel series of CRF-1 receptor antagonists.

Mark T. Kershaw, J. Kehne, J. Chandrasekhar, 2008, Bioorganic & medicinal chemistry letters.

trans-1-[(2-Phenylcyclopropyl)methyl]-4-arylpiperazines: mixed dopamine D(2)/D(4) receptor antagonists as potential antipsychotic agents.

D. Hoffman, H. Zhao, K. Hodgetts, 2000, Journal of medicinal chemistry.

The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences

D. Hoffman, P. R. Dickson, J. BeningerRicahrd, 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

D. Hoffman, 2005, Journal of Neural Transmission / General Section JNT.

Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin

R. Wise, D. Hoffman, 2005, Psychopharmacology.

Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections

R. Wise, D. Hoffman, 2005, Psychopharmacology.

Feeding behavior in rats is differentially affected by pimozide treatment depending on prior experience

R. Beninger, D. Hoffman, 1986, Pharmacology Biochemistry and Behavior.

Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning

R. Beninger, D. Hoffman, 1988, Pharmacology Biochemistry and Behavior.

The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats

R. Beninger, D. Hoffman, 1989, Pharmacology Biochemistry and Behavior.

Indoline and Piperazine Containing Derivatives as a Novel Class of Mixed D2/D4 Receptor Antagonists. Part 2. Asymmetric Synthesis and Biological Evaluation.

D. Hoffman, R. Brodbeck, A. Thurkauf, 2003 .

The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats

D. Hoffman, 1994, Pharmacology Biochemistry and Behavior.

The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801

D. Hoffman, J. Cassella, H. Donovan, 2005, Psychopharmacology.

Effects of typical, atypical, and novel antipsychotic drugs on amphetamine‐induced place conditioning in rats

D. Hoffman, H. Donovan, 1995 .

Receptor subtype-specific dopaminergic agents and unconditioned behavior.

R. Beninger, D. Hoffman, E. Mazurski, 1991, Polish journal of pharmacology and pharmacy.

The use of place conditioning in studying the neuropharmacology of drug reinforcement.

D. Hoffman, 1989, Brain research bulletin.

Conditional tolerance to haloperidol-induced catalepsy: striatal dopamine receptor supersensitivity is a possible explanation

R. Beninger, D. Hoffman, 2004, Psychopharmacology.